Strides Pharma

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE939A01011
NSEID: STAR
BSEID: 532531
View on NSE | View on BSE

INR

1,004.00

3.35 (0.33%)

BSENSE

Apr 13

BSE+NSE Vol: 2.71 lacs

{
  "main_header": {
    "sid": 688428,
    "name": "Strides Pharma",
    "stock_name": "Strides Pharma",
    "full_name": "Strides Pharma Science Ltd",
    "name_url": "stocks-analysis/strides-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,004.00",
    "chg": 3.35,
    "chgp": "0.33%",
    "dir": 1,
    "prev_price": "1,000.65",
    "mcapval": "9,121.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532531,
    "symbol": "STAR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE939A01011",
    "curr_date": "Apr 13",
    "curr_time": "",
    "bse_nse_vol": "2.71 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 13, 2026",
    "traded_date_str": "2026 04 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/strides-pharma-688428-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Strides Pharma Gains 1.95%: Four Key Technical and Financial Developments This Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-gains-195-four-key-technical-and-financial-developments-this-week-3942950",
        "imagepath": "",
        "date": "2026-04-11 16:03:50",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>6 Apr:</strong> Week opens at Rs.981.50</p>\n                    <p><strong>7 Apr:</strong> Upgraded to Hold on technical and financial improvements</p>\n                    <p><strong>8 Apr:</strong> Formation of Golden Cross signalling potential bullish breakout</p>\n                    <p><strong>9 Apr:</strong> Technical momentum shifts to bullish amid mixed indicators</p>\n                    <p><strong>10 Apr:</strong> Week closes at Rs.1,000.65 (+1.95%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.981.50</div></div>\n                    <div class=\"..."
      },
      {
        "title": "Strides Pharma Science Ltd Technical Momentum Shifts to Bullish Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-technical-momentum-shifts-to-bullish-amid-mixed-indicators-3938686",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/StridesPharmaSc_technicaldot_3938686.png",
        "date": "2026-04-09 08:03:51",
        "description": "Strides Pharma Science Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a modest day decline of 2.73%, the stock’s technical indicators reveal a complex but predominantly positive outlook, supported by improving moving averages and mixed signals from momentum oscillators. This analysis delves into the recent technical parameter changes, evaluating key indicators such as MACD, RSI, Bollinger Bands, and moving averages to provide a comprehensive view of the stock’s near-term trajectory."
      },
      {
        "title": "Golden Cross Confirmed: Do Strides Pharma Science Ltd's Other Technical Indicators Agree?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-forms-golden-cross-signalling-potential-bullish-breakout-3938273",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/StridesPharmaSc_goldencross_3938273.png",
        "date": "2026-04-08 18:00:22",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Strides Pharma Science Ltd, signalling a golden cross on 8 Apr 2026. Yet, the stock declined 2.73% on the day the cross formed, while monthly momentum indicators remain mildly bearish. This juxtaposition of signals calls for a detailed examination of the technical and fundamental context behind the crossover."
      },
      {
        "title": "Strides Pharma Science Ltd Upgraded to Hold on Technical and Financial Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/strides-pharma-science-ltd-upgraded-to-hold-on-technical-and-financial-improvements-3935721",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/StridesPharmaSc_mojoScore_3935721.png",
        "date": "2026-04-07 08:19:53",
        "description": "Strides Pharma Science Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators alongside robust quarterly financial performance. The upgrade, effective from 6 April 2026, is underpinned by enhanced technical trends, attractive valuation metrics, and positive financial results, although some long-term fundamental challenges remain."
      },
      {
        "title": "Strides Pharma Science Ltd Shows Positive Momentum Shift Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-shows-positive-momentum-shift-amid-mixed-technical-signals-3935432",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/StridesPharmaSc_technicaldot_3935432.png",
        "date": "2026-04-07 08:03:24",
        "description": "Strides Pharma Science Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. This change is underscored by mixed signals from key indicators such as MACD, RSI, and moving averages, reflecting a nuanced market sentiment amid broader sector volatility."
      },
      {
        "title": "Strides Pharma Science Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/strides-pharma-science-ltd-is-rated-sell-3927394",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/StridesPharmaSc_mojoScore_3927394.png",
        "date": "2026-03-31 10:10:02",
        "description": "Strides Pharma Science Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 March 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 31 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Strides Pharma Declines 1.89%: Death Cross and Downgrade Signal Caution",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-declines-189-death-cross-and-downgrade-signal-caution-3922409",
        "imagepath": "",
        "date": "2026-03-28 17:12:45",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Mar 16:</strong> Stock opens at Rs.890.95, down 3.39% amid broader market gains</p>\n                    <p><strong>Mar 18:</strong> Strong rebound to Rs.905.10 (+3.29%) on increased volume</p>\n                    <p><strong>Mar 19:</strong> Formation of Death Cross signals potential bearish trend</p>\n                    <p><strong>Mar 20:</strong> Downgrade to Sell rating and mildly bearish technical shift</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.922.25</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div>..."
      },
      {
        "title": "Strides Pharma Science Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/strides-pharma-science-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3902383",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/StridesPharmaSc_mojoScore_3902383.png",
        "date": "2026-03-20 08:05:54",
        "description": "Strides Pharma Science Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 19 March 2026. This change is primarily driven by a deterioration in technical indicators, despite the company’s robust recent financial performance and attractive valuation metrics. The downgrade reflects a nuanced assessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals."
      },
      {
        "title": "Strides Pharma Science Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-faces-mildly-bearish-technical-shift-amid-mixed-momentum-signals-3902267",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/StridesPharmaSc_technicaldot_3902267.png",
        "date": "2026-03-20 08:02:18",
        "description": "Strides Pharma Science Ltd has experienced a subtle but notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish stance. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, reflecting a complex interplay of market forces impacting the small-cap pharmaceutical player."
      }
    ],
    "total": 670,
    "sid": "688428",
    "stock_news_url": "https://www.marketsmojo.com/news/strides-pharma-science-688428"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "02-Apr-2026",
      "details": "Certificate in terms of regulation 74(5) of SEBI (Depository and Participants) Regulations 2018 for the quarter ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2026",
      "details": "Intimation regarding closure of Trading Window for the quarter and year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "17-Mar-2026",
      "details": "Strides Strengthens its Africa Business with the Acquisition of Multiple Generic Brands from Sandoz",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Strides Pharma Science Ltd has declared <strong>40%</strong> dividend, ex-date: 22 Jul 25",
          "dt": "2025-07-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Strides Pharma Gains 1.95%: Four Key Technical and Financial Developments This Week

2026-04-11 16:03:50

Key Events This Week

6 Apr: Week opens at Rs.981.50

7 Apr: Upgraded to Hold on technical and financial improvements

8 Apr: Formation of Golden Cross signalling potential bullish breakout

9 Apr: Technical momentum shifts to bullish amid mixed indicators

10 Apr: Week closes at Rs.1,000.65 (+1.95%)

Week Open

Rs.981.50

Read full news article

Strides Pharma Science Ltd Technical Momentum Shifts to Bullish Amid Mixed Indicators

2026-04-09 08:03:51

Strides Pharma Science Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a modest day decline of 2.73%, the stock’s technical indicators reveal a complex but predominantly positive outlook, supported by improving moving averages and mixed signals from momentum oscillators. This analysis delves into the recent technical parameter changes, evaluating key indicators such as MACD, RSI, Bollinger Bands, and moving averages to provide a comprehensive view of the stock’s near-term trajectory.

Read full news article

Golden Cross Confirmed: Do Strides Pharma Science Ltd's Other Technical Indicators Agree?

2026-04-08 18:00:22

The 50-day moving average has crossed above the 200-day moving average for Strides Pharma Science Ltd, signalling a golden cross on 8 Apr 2026. Yet, the stock declined 2.73% on the day the cross formed, while monthly momentum indicators remain mildly bearish. This juxtaposition of signals calls for a detailed examination of the technical and fundamental context behind the crossover.

Read full news article

Strides Pharma Science Ltd Upgraded to Hold on Technical and Financial Improvements

2026-04-07 08:19:53

Strides Pharma Science Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators alongside robust quarterly financial performance. The upgrade, effective from 6 April 2026, is underpinned by enhanced technical trends, attractive valuation metrics, and positive financial results, although some long-term fundamental challenges remain.

Read full news article

Strides Pharma Science Ltd Shows Positive Momentum Shift Amid Mixed Technical Signals

2026-04-07 08:03:24

Strides Pharma Science Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. This change is underscored by mixed signals from key indicators such as MACD, RSI, and moving averages, reflecting a nuanced market sentiment amid broader sector volatility.

Read full news article

Strides Pharma Science Ltd is Rated Sell

2026-03-31 10:10:02

Strides Pharma Science Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 March 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 31 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Strides Pharma Declines 1.89%: Death Cross and Downgrade Signal Caution

2026-03-28 17:12:45

Key Events This Week

Mar 16: Stock opens at Rs.890.95, down 3.39% amid broader market gains

Mar 18: Strong rebound to Rs.905.10 (+3.29%) on increased volume

Mar 19: Formation of Death Cross signals potential bearish trend

Mar 20: Downgrade to Sell rating and mildly bearish technical shift

Read full news article

Strides Pharma Science Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-03-20 08:05:54

Strides Pharma Science Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 19 March 2026. This change is primarily driven by a deterioration in technical indicators, despite the company’s robust recent financial performance and attractive valuation metrics. The downgrade reflects a nuanced assessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals.

Read full news article

Strides Pharma Science Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum Signals

2026-03-20 08:02:18

Strides Pharma Science Ltd has experienced a subtle but notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish stance. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, reflecting a complex interplay of market forces impacting the small-cap pharmaceutical player.